720-777-0123
-
Your Visit
Click to find the locations nearest you
Find locations by region
See all locations -
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
Kevin Lillehei, MD
- Chair of Neurosurgery
Provider's Specialties
- Neurosurgery
Provider's location(s)
Location information is not available.
Insurance plans accepted
We participate with most major health insurance plans and national transplant networks.
Prepare for your visit
We want to make sure you know what to expect before you arrive.
Get to know Kevin Lillehei, MD
Conditions Treated
- Brain Tumors
- Pituitary Disorders
- Craniopharyngioma
Languages spoken
- English
Experience and background
I focus on Neuro-oncology and treating tumors including pituitary tumors, benign and malignant gliomas, spinal cord tumors, acoustic neuromas, complex skull base lesions and peripheral nerve injuries.
Undergraduate 1975
Cornell University (NY)
Medical Education 1979
University of Minnesota Medical School
Internship 1980
University of Michigan Hospitals and Health Centers Program
Residency 1985
University of Michigan Hospitals and Health Centers Program
For Patients:
Dr. Lillehei is Director of the Neurosurgery Neuro-Oncology laboratory with his research interests revolving around the treatment of malignant gliomas. In particular, he is interested in studying the role of the immune system in intracranial tumor recognition and eradication, and is exploring the use of various tumor vaccines as adjuvant therapy for the treatment of malignant gliomas.
Dr. Lillehei is Director of the Neurosurgery Neuro-Oncology laboratory with his research interests revolving around the treatment of malignant gliomas. In particular, he is interested in studying the role of the immune system in intracranial tumor recognition and eradication, and is exploring the use of various tumor vaccines as adjuvant therapy for the treatment of malignant gliomas.
For Referring Providers:
Dr. Lillehei is Director of the Neurosurgery Neuro-Oncology laboratory with his research interests revolving around the treatment of malignant gliomas. In particular, he is interested in studying the role of the immune system in intracranial tumor recognition and eradication, and is exploring the use of various tumor vaccines as adjuvant therapy for the treatment of malignant gliomas.
Dr. Lillehei is Director of the Neurosurgery Neuro-Oncology laboratory with his research interests revolving around the treatment of malignant gliomas. In particular, he is interested in studying the role of the immune system in intracranial tumor recognition and eradication, and is exploring the use of various tumor vaccines as adjuvant therapy for the treatment of malignant gliomas.
5280 Top Doc 2000
11 years in a row
5280 Magazine
Guest Examiner 2006
Oral Neurosurgical Board Examinations
American Board of Neurological Surgery
Visiting Professor 2006
Univ of Texas Southwestern
Top Surgeon - Neurosurgery 2007
Consumer's Research Council of America
Who's Who in Medicine and Healthcare 2007
Marquis
Peak Performer Award 2010
Rocky Mountain Hospital Medicine Symposium
Faculty member of
Meet other experts
Randy Wilkening, MD
Neonatal/Perinatal Medicine, Pediatrics
Patient ratings and reviews are not available Why?
Kimberly O'Hara, MD
Pediatric Hospital Medicine, Pediatrics
Patient ratings and reviews are not available Why?
Christopher Schumann, CAA
Certified Anesthesiologist Assistant
Patient ratings and reviews are not available Why?